1st ed. 2019 Edition
by Todd E. Druley (Editor)
This volume provides a concise yet comprehensive overview of
minimal residual disease (MRD) testing. The text reviews the history of
MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma,
molecular diagnostics for MRD analysis in hematopoietic malignancies,
the use of "difference from normal" flow cytometry in monitoring AML
response, ML-DS for measurable residual disease detection, and
advancements in next generation sequencing for detecting MRD.
Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is
a valuable resource for hematologists, oncologists, pathologists, and
radiologists on the variety of technologies available to detect MRD and
how best to integrate these platforms into clinical practice.
